Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Ceftibuten + ledaborbactam etzadroxil) by VenatoRx Pharmaceuticals for Enterobacteriaceae Infections: Likelihood of Approval
(Ceftibuten + ledaborbactam etzadroxil) is under clinical development by VenatoRx Pharmaceuticals and currently in Phase I for Enterobacteriaceae Infections. According...
(Ceftibuten + ledaborbactam etzadroxil) by VenatoRx Pharmaceuticals for Urinary Tract Infections: Likelihood of Approval
(Ceftibuten + ledaborbactam etzadroxil) is under clinical development by VenatoRx Pharmaceuticals and currently in Phase I for Urinary Tract Infections....
(Ceftibuten + ledaborbactam etzadroxil) by VenatoRx Pharmaceuticals for Pyelonephritis: Likelihood of Approval
(Ceftibuten + ledaborbactam etzadroxil) is under clinical development by VenatoRx Pharmaceuticals and currently in Phase I for Pyelonephritis. According to...